| Not Yet Recruiting | Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia NCT07453836 | China Immunotech (Beijing) Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases NCT07441525 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | EARLY_Phase 1 |
| Not Yet Recruiting | A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia NCT07287930 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Recruiting | A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia NCT07175493 | Keymed Biosciences Co.Ltd | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antib NCT07190261 | Bing Han | Phase 2 |
| Not Yet Recruiting | A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmun NCT07149818 | Peking Union Medical College Hospital | — |
| Not Yet Recruiting | UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases NCT06978738 | Changzhou No.2 People's Hospital | Phase 1 |
| Recruiting | Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia NCT06921980 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Not Yet Recruiting | A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia NCT06770504 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Completed | A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia NCT07075484 | China Immunotech (Beijing) Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. NCT06733610 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Recruiting | Safety Study of CC312 in Autoimmune Disease Patients NCT06888960 | CytoCares Inc | EARLY_Phase 1 |
| Active Not Recruiting | CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy. NCT06231368 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Unknown | CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy NCT06212154 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Recruiting | Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL NCT05694312 | Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 |
| Unknown | Presence of Circulating Cluster of Differentiation 4 Positive 28 Null T Helper Lymphocytes(CD4+CD28-) in Patie NCT05711264 | Assiut University | — |
| Terminated | PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More NCT05676697 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Not Yet Recruiting | The Significance of Release of T-follicular Helper and T-follicular Regulatory Cells in Autoimmune Haemolytic NCT04814394 | Assiut University | — |
| Recruiting | Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune He NCT05089227 | Centre Hospitalier Universitaire Dijon | Phase 2 |
| Unknown | A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmu NCT05263817 | Zhejiang University | EARLY_Phase 1 |
| Unknown | Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus NCT05057481 | Assiut University | Phase 3 |
| Active Not Recruiting | Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic NCT04657094 | City of Hope Medical Center | Phase 2 |
| Withdrawn | A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP NCT04039477 | Kezar Life Sciences, Inc. | Phase 2 |
| Completed | Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia NCT04083014 | Peking Union Medical College Hospital | Phase 2 |
| Unknown | Data Registry of Auto Immune Hemolytic Anemia NCT04024202 | Sanquin Research & Blood Bank Divisions | — |
| Recruiting | Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune NCT05931718 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Unknown | Tacrolimus Treatment for Refractory Autoimmune Cytopenia NCT03918265 | Peking Union Medical College Hospital | Phase 4 |
| Recruiting | Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia NCT04005638 | University Hospital, Bordeaux | — |
| Completed | A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia NCT03538041 | Incyte Corporation | Phase 2 |
| Completed | Severe Immune Cytopenia Registry Www.Sic-reg.Org NCT03576742 | Medical University of Graz | — |
| Completed | Clinical Characteristics and Treatment Outcomes of Patients With Autoimmune Hemolytic Anemia NCT03269292 | Assiut University | — |
| Completed | Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventi NCT02389231 | University Hospital, Bordeaux | Phase 1 / Phase 2 |
| Completed | Role of T Follicular Helper Cells in Autoimmune Hemolytic Anemia (TFH in AIHA) NCT02828670 | Centre Hospitalier Universitaire Dijon | — |
| Completed | Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. NCT04057703 | University Hospital, Bordeaux | — |
| Completed | Immunopathology of Autoimmune Hemolytic Anemia NCT02158195 | Centre Hospitalier Universitaire Dijon | — |
| Recruiting | French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia NCT02877706 | University Hospital, Toulouse | — |
| Completed | Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease NCT02689986 | Helse Fonna | Phase 2 |
| Recruiting | OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia NCT05937828 | University Hospital, Bordeaux | — |
| Completed | Treatment of Autoimmune Thrombocytopenia (AITP) NCT00001630 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |